These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 11757484)
1. [The quantitative analysis of E6 HPV and P53 genes expression by QPCR (TaqMan) in the assessment of surgical treatment range in vulvar carcinoma induced by HTV infection]. Olejek A; Mazurek U; Kuśmierz D; Rzempołuch J; Wilczok T Ginekol Pol; 2001 Sep; 72(9):723-7. PubMed ID: 11757484 [TBL] [Abstract][Full Text] [Related]
2. [The assessment of expression of kininogen and bradykinin receptors genes in different vulvar pathologies by QPCR (TaqMan)]. Olejek A; Mazurek U; Orchel J; Rzempołuch J; Wilczok T Ginekol Pol; 2001 Sep; 72(9):717-22. PubMed ID: 11757483 [TBL] [Abstract][Full Text] [Related]
3. A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas. Koyamatsu Y; Yokoyama M; Nakao Y; Fukuda K; Saito T; Matsukuma K; Iwasaka T Gynecol Oncol; 2003 Sep; 90(3):547-51. PubMed ID: 13678722 [TBL] [Abstract][Full Text] [Related]
4. p53 protein overexpression is common and independent of human papillomavirus infection in squamous cell carcinoma of the vulva. Kagie MJ; Kenter GG; Tollenaar RA; Hermans J; Trimbos JB; Fleuren GJ Cancer; 1997 Oct; 80(7):1228-33. PubMed ID: 9317172 [TBL] [Abstract][Full Text] [Related]
5. A panel of p16(INK4A), MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma. Hoevenaars BM; van der Avoort IA; de Wilde PC; Massuger LF; Melchers WJ; de Hullu JA; Bulten J Int J Cancer; 2008 Dec; 123(12):2767-73. PubMed ID: 18798277 [TBL] [Abstract][Full Text] [Related]
6. Human papilloma virus, vulvar dystrophy, and vulvar carcinoma: differential expression of human papillomavirus and vulvar dystrophy in the presence and absence of squamous cell carcinoma of the vulva. Sagerman PM; Choi YJ; Hu Y; Niedt GW Gynecol Oncol; 1996 Jun; 61(3):328-32. PubMed ID: 8641610 [TBL] [Abstract][Full Text] [Related]
7. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252 [TBL] [Abstract][Full Text] [Related]
8. Papillomavirus, p53 alteration, and primary carcinoma of the vulva. Pilotti S; D'Amato L; Della Torre G; Donghi R; Longoni A; Giarola M; Sampietro G; De Palo G; Pierotti MA; Rilke F Diagn Mol Pathol; 1995 Dec; 4(4):239-48. PubMed ID: 8634779 [TBL] [Abstract][Full Text] [Related]
9. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150 [TBL] [Abstract][Full Text] [Related]
10. The presence of HPV 16, 18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia. Menczer J; Fintsi Y; Arbel-Alon S; Tell L; Friedman E; Jackman A; Sherman L Eur J Gynaecol Oncol; 2000; 21(1):30-4. PubMed ID: 10726615 [TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma of the vulva: study of ploidy, HPV, p53, and pRb. Lerma E; Matias-Guiu X; Lee SJ; Prat J Int J Gynecol Pathol; 1999 Jul; 18(3):191-7. PubMed ID: 12090585 [TBL] [Abstract][Full Text] [Related]
12. Carcinoma of the vulva: HPV and p53 mutations. Lee YY; Wilczynski SP; Chumakov A; Chih D; Koeffler HP Oncogene; 1994 Jun; 9(6):1655-9. PubMed ID: 8183560 [TBL] [Abstract][Full Text] [Related]
13. Characteristics of vulvar squamous cell carcinoma in Japanese women. Osakabe M; Hayashi M; Katayama Y; Emura I; Nemoto K; Umezu H; Saitoh K; Motoyama T Pathol Int; 2007 Jun; 57(6):322-7. PubMed ID: 17539962 [TBL] [Abstract][Full Text] [Related]
14. The absence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to the HPV-independent pathway as the causative agent for vulvar squamous cell carcinoma and its precursor simplex VIN in a young patient. Kruse AJ; Bottenberg MJ; Tosserams J; Slangen B; van Marion AM; van Trappen PO Int J Gynecol Pathol; 2008 Oct; 27(4):591-5. PubMed ID: 18753959 [TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: detection and prognostic significance. Ansink AC; Krul MR; De Weger RA; Kleyne JA; Pijpers H; Van Tinteren H; De Kraker EW; Helmerhorst TJ; Heintz AP Gynecol Oncol; 1994 Feb; 52(2):180-4. PubMed ID: 8314136 [TBL] [Abstract][Full Text] [Related]
16. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned. van de Nieuwenhof HP; van Kempen LC; de Hullu JA; Bekkers RL; Bulten J; Melchers WJ; Massuger LF Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2061-7. PubMed ID: 19567503 [TBL] [Abstract][Full Text] [Related]
17. Gains of chromosome region 3q26 in intraepithelial neoplasia and invasive squamous cell carcinoma of the vulva are frequent and independent of HPV status. Aulmann S; Schleibaum J; Penzel R; Schirmacher P; Gebauer G; Sinn HP J Clin Pathol; 2008 Sep; 61(9):1034-7. PubMed ID: 18559375 [TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus infection and p53 nuclear overexpression in anal canal carcinoma. Indinnimeo M; Cicchini C; Stazi A; Giarnieri E; French D; Limiti MR; Ghini C; Vecchione A J Exp Clin Cancer Res; 1999 Mar; 18(1):47-52. PubMed ID: 10374676 [TBL] [Abstract][Full Text] [Related]
19. Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma--relation to radiotherapy response and survival. Friesland S; Mellin H; Munck-Wikland E; Nilsson A; Lindholm J; Dalianis T; Lewensohn R Anticancer Res; 2001; 21(1B):529-34. PubMed ID: 11299799 [TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma of the endometrium with human papillomavirus type 31 and without tumor suppressor gene p53 mutation. Kataoka A; Nishida T; Sugiyama T; Hori K; Honda S; Yakushiji M Gynecol Oncol; 1997 Apr; 65(1):180-4. PubMed ID: 9103411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]